Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029149242> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2029149242 abstract "Despite improvement in our understanding of leukemogenic mechanisms, the majority of AML patients (pts) fail to achieve long-term survival and die of their disease. Therefore, new therapeutic options are needed. Silvestrol, a natural product isolated from Aglaia foveolata, has been shown to have potent antitumor activity, most likely through inhibition of initiation of translation. Promising synergistic effects of silvestrol with chemotherapy were shown in AML, but the exact mechanism mediating the antileukemic activity remains to be fully elucidated. Recently, microRNAs (miRs), short non-coding RNAs, have been recognized to contribute to leukemogenesis by inhibiting expression of targeted tumor suppressor genes. Therefore, we hypothesized that the antileukemic effect of silvestrol may at least be partly mediated by activity on miRs. We investigated the effects of silvestrol on the expression of a panel of miRs previously linked to AML (miR-29a, miR-29b, miR-29c, miR-181a, miR-34a & miR-155) by quantitative RT-PCR in representative AML cell lines (MV4-11, Kasumi-1, K562). Among the miRs measured, miR-155 was the only one found to be altered, with >40% reduction from baseline following 24h silvestrol treatment (50nM). MiR-155 has a known oncogenic effect in leukemia and is up-regulated in FLT3-ITD (internal tandem duplication)-positive blasts. FLT3 encodes a tyrosine kinase membrane receptor, and the FLT3-ITD mutation is carried by ∼30% of all AML pts. FLT3-ITD supports abnormal myeloid blast proliferation and survival, and predicts dismal outcome. Silvestrol treatment of FLT3-ITD-positive MV4-11 cells resulted in a sustained 40% decrease of miR-155 expression observed as early as 6h post-treatment, as well as down-regulation (80%) of FLT3 mRNA and protein expression compared with vehicle-treated controls as measured by quantitative RT-PCR and immunoblotting respectively. We confirmed this finding by demonstrating a significant reduction of FLT3 surface expression by flow cytometry. These effects were associated with a significant antiproliferative and apoptotic activity of silvestrol on MV4-11 cells (IC 50 Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3558." @default.
- W2029149242 created "2016-06-24" @default.
- W2029149242 creator A5003456929 @default.
- W2029149242 creator A5003617778 @default.
- W2029149242 creator A5004233773 @default.
- W2029149242 creator A5008148729 @default.
- W2029149242 creator A5012262072 @default.
- W2029149242 creator A5016975904 @default.
- W2029149242 creator A5022067885 @default.
- W2029149242 creator A5023876572 @default.
- W2029149242 creator A5039118991 @default.
- W2029149242 creator A5050101670 @default.
- W2029149242 creator A5050961821 @default.
- W2029149242 creator A5051619378 @default.
- W2029149242 creator A5055443268 @default.
- W2029149242 creator A5056314507 @default.
- W2029149242 creator A5062250759 @default.
- W2029149242 creator A5065921814 @default.
- W2029149242 date "2010-04-15" @default.
- W2029149242 modified "2023-09-25" @default.
- W2029149242 title "Abstract 3558: The natural product silvestrol decreases oncogenic FLT3 andmiR-155levels inFLT3-ITD positive Acute Myeloid Leukemia (AML) cells" @default.
- W2029149242 doi "https://doi.org/10.1158/1538-7445.am10-3558" @default.
- W2029149242 hasPublicationYear "2010" @default.
- W2029149242 type Work @default.
- W2029149242 sameAs 2029149242 @default.
- W2029149242 citedByCount "0" @default.
- W2029149242 crossrefType "proceedings-article" @default.
- W2029149242 hasAuthorship W2029149242A5003456929 @default.
- W2029149242 hasAuthorship W2029149242A5003617778 @default.
- W2029149242 hasAuthorship W2029149242A5004233773 @default.
- W2029149242 hasAuthorship W2029149242A5008148729 @default.
- W2029149242 hasAuthorship W2029149242A5012262072 @default.
- W2029149242 hasAuthorship W2029149242A5016975904 @default.
- W2029149242 hasAuthorship W2029149242A5022067885 @default.
- W2029149242 hasAuthorship W2029149242A5023876572 @default.
- W2029149242 hasAuthorship W2029149242A5039118991 @default.
- W2029149242 hasAuthorship W2029149242A5050101670 @default.
- W2029149242 hasAuthorship W2029149242A5050961821 @default.
- W2029149242 hasAuthorship W2029149242A5051619378 @default.
- W2029149242 hasAuthorship W2029149242A5055443268 @default.
- W2029149242 hasAuthorship W2029149242A5056314507 @default.
- W2029149242 hasAuthorship W2029149242A5062250759 @default.
- W2029149242 hasAuthorship W2029149242A5065921814 @default.
- W2029149242 hasConcept C104317684 @default.
- W2029149242 hasConcept C145059251 @default.
- W2029149242 hasConcept C203014093 @default.
- W2029149242 hasConcept C2778461978 @default.
- W2029149242 hasConcept C2778729363 @default.
- W2029149242 hasConcept C2779282312 @default.
- W2029149242 hasConcept C502942594 @default.
- W2029149242 hasConcept C54355233 @default.
- W2029149242 hasConcept C86803240 @default.
- W2029149242 hasConceptScore W2029149242C104317684 @default.
- W2029149242 hasConceptScore W2029149242C145059251 @default.
- W2029149242 hasConceptScore W2029149242C203014093 @default.
- W2029149242 hasConceptScore W2029149242C2778461978 @default.
- W2029149242 hasConceptScore W2029149242C2778729363 @default.
- W2029149242 hasConceptScore W2029149242C2779282312 @default.
- W2029149242 hasConceptScore W2029149242C502942594 @default.
- W2029149242 hasConceptScore W2029149242C54355233 @default.
- W2029149242 hasConceptScore W2029149242C86803240 @default.
- W2029149242 hasLocation W20291492421 @default.
- W2029149242 hasOpenAccess W2029149242 @default.
- W2029149242 hasPrimaryLocation W20291492421 @default.
- W2029149242 hasRelatedWork W1778624565 @default.
- W2029149242 hasRelatedWork W2050609162 @default.
- W2029149242 hasRelatedWork W2120940493 @default.
- W2029149242 hasRelatedWork W2370830486 @default.
- W2029149242 hasRelatedWork W2534073704 @default.
- W2029149242 hasRelatedWork W2554931018 @default.
- W2029149242 hasRelatedWork W2558756623 @default.
- W2029149242 hasRelatedWork W2568509642 @default.
- W2029149242 hasRelatedWork W2570759675 @default.
- W2029149242 hasRelatedWork W2589480094 @default.
- W2029149242 hasRelatedWork W2590495004 @default.
- W2029149242 hasRelatedWork W2610150407 @default.
- W2029149242 hasRelatedWork W2887715275 @default.
- W2029149242 hasRelatedWork W2913758200 @default.
- W2029149242 hasRelatedWork W2979594647 @default.
- W2029149242 hasRelatedWork W3096826855 @default.
- W2029149242 hasRelatedWork W3147241457 @default.
- W2029149242 hasRelatedWork W3158809845 @default.
- W2029149242 hasRelatedWork W3196574574 @default.
- W2029149242 hasRelatedWork W3210605736 @default.
- W2029149242 isParatext "false" @default.
- W2029149242 isRetracted "false" @default.
- W2029149242 magId "2029149242" @default.
- W2029149242 workType "article" @default.